A compound called TMA produced by gut bacteria may help prevent and manage type 2 diabetes by reducing inflammation and improving insulin response, offering a potential new avenue for treatment and prevention, though more research is needed.
A study suggests that a molecule produced by gut bacteria, TMA, may reduce inflammation and improve insulin sensitivity by blocking an immune pathway, offering potential new approaches for managing type 2 diabetes through diet and microbiome modulation.
Scientists have discovered that a molecule called TMA, produced by gut microbes from dietary choline, can reduce inflammation linked to diabetes by inhibiting the immune protein IRAK4, potentially leading to new treatments for insulin resistance and type 2 diabetes.